Hair Straightener Cancer Lawsuit [September 2026 Update] | Chemical Hair Straightener Lawsuit

Arizona has sued L’Oreal, alleging the cosmetics company concealed evidence that its chemical hair relaxer products could increase women’s risk of cancer.

Arizona Attorney General Kris Mayes filed the lawsuit Friday in Maricopa County Superior Court against L’Oreal USA, parent company L’Oreal S.A. and SoftSheen-Carson.

Arizona is the first state to sue over alleged cancer risks tied to hair relaxers.

The complaint alleges the companies marketed and sold hair relaxers, sold under brands including Dark and Lovely and Optimum, without disclosing links to ovarian and uterine cancers.

The products are marketed primarily to Black women and, in some cases, children.

Mayes said the companies knew or should have known of the risks and prioritized profits over consumer safety.

Arizona is seeking penalties and damages, along with a court order requiring L’Oreal to warn consumers of cancer risks or stop selling the products.

The lawsuit cites a 2022 National Institutes of Health study finding women who used the products several times a year were more than twice as likely to develop uterine cancer.

L’Oreal disputes the claims.

A company spokesperson said its products undergo rigorous safety reviews and that the cited study made no finding of a causal connection between relaxer use and the health conditions alleged in the litigation.

L’Oreal already faces more than 12,000 similar lawsuits consolidated in a federal multidistrict litigation based in Chicago, with trials possibly beginning in 2027.

The Hair Relaxer MDL added 350 cases between August and September, increasing from 11,779 to 12,129.

The renewed growth comes as the litigation approaches key Daubert rulings that will determine which expert testimony on the alleged connection between chemical hair relaxers and cancer can be presented at future trials.

With more than 12,000 cases now pending, the upcoming expert rulings could significantly influence bellwether preparations and potential settlement discussions.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chat feature on this page to see if you qualify to file a claim instantly.

The Hair Relaxer MDL decreased by 98 cases between July and August, declining from 11,877 to 11,779.

The slight decline comes as the litigation continues through the critical Daubert phase, with the court evaluating whether expert testimony on the link between hair relaxers and cancer will be admitted before bellwether trials.

Those rulings are expected to play a major role in any future settlement discussions.

Despite the month-over-month decrease, the Hair Relaxer MDL remains one of the largest active mass torts in the federal court system.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A new study published in the Journal of the American Academy of Dermatology identified an association between frequent hair relaxer use and an increased risk of several hormone-related cancers, adding to the growing body of research examining the long-term health effects of chemical hair straightening products.

Researchers emphasized that while the findings identify an association, additional studies are needed to determine whether the relationship is causal.

The study contributes to an expanding field of research investigating whether repeated exposure to endocrine-disrupting chemicals commonly found in some hair relaxers may increase the risk of developing hormone-sensitive cancers.

Scientists continue to evaluate the biological mechanisms that could explain these findings and whether certain ingredients or patterns of use present greater risks than others.

The research comes as thousands of hair relaxer lawsuits continue to move through the courts. Plaintiffs allege manufacturers failed to adequately warn consumers that long-term use of chemical hair straighteners could increase the risk of developing cancer.

As additional scientific studies are published, they are expected to play an important role in evaluating the evidence presented throughout the ongoing litigation.

Illinois lawmakers have approved legislation that would prohibit the sale of cosmetic products containing several chemicals linked to serious health concerns, strengthening consumer protections and increasing oversight of ingredients used in beauty products.

The measure is designed to reduce exposure to substances that have been associated with cancer, reproductive harm, and other adverse health effects.

While the legislation does not specifically target hair relaxers, it reflects growing concern over the safety of chemicals commonly used in cosmetic and personal care products.

The bill comes as manufacturers of chemical hair straighteners continue to face thousands of lawsuits alleging they failed to warn consumers about potential health risks associated with long-term use.

The growing regulatory focus on cosmetic ingredients follows years of scientific research examining potential links between certain chemicals in hair relaxers and hormone-related cancers.

As lawmakers continue to scrutinize these products, plaintiffs in the hair relaxer litigation argue that stronger warnings and safer formulations could have helped reduce consumers’ exposure to potentially harmful chemicals.

The Hair Relaxer MDL added 154 cases between June and July, increasing from 11,723 to 11,877.

The litigation continued to grow as the court approached the critical Daubert phase, where judges will determine which expert testimony can be presented at future bellwether trials.

Settlement speculation also increased during the month as both sides prepared for those evidentiary rulings.

The upcoming Daubert decisions are expected to shape the timeline for the first Hair Relaxer bellwether trials and any potential settlement discussions.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Plaintiffs in the Hair Relaxer MDL are asking the court to require depositions of several current and former L’Oréal executives.

They argue the executives have firsthand knowledge of the company’s Dark & Lovely hair relaxer products, including product development, safety testing, marketing, and internal discussions about potential health risks.

L’Oréal has objected to some of the requested depositions, and the court is now considering the discovery dispute.

The request comes as both sides continue preparing their cases through fact discovery and work toward the next phase of the litigation.

Plaintiffs contend that testimony from senior executives could help establish what the company knew about the potential health risks associated with chemical hair relaxers.

They also argue the depositions could clarify when the company became aware of those risks.

The testimony may further address whether L’Oréal provided consumers with adequate warnings about the products.

If the court permits the depositions, the testimony could become an important part of the evidence used as the litigation moves closer to expert challenges and future bellwether trial preparations.

The Hair Relaxer MDL is approaching a pivotal stage, with expert briefing underway and both sides filing responses and replies ahead of anticipated Daubert proceedings.

The litigation now includes nearly 12,000 pending cases, making it one of the largest active mass torts in federal court.

As the parties finalize challenges to expert testimony, attention is turning to whether settlement discussions could emerge before the court holds Daubert hearings.

Some mass-tort litigations reach settlements after expert issues are fully briefed but before oral argument.

However, attorneys following the Hair Relaxer litigation remain divided on whether that timeline is likely to be met here.

The outcome of the upcoming Daubert process will play a significant role in shaping the strength of the parties’ cases and could influence the pace of any future settlement negotiations.

The federal judge overseeing the Hair Relaxer multidistrict litigation has reappointed 38 plaintiffs’ attorneys to leadership positions as the litigation enters its third year and moves closer to bellwether trials.

The leadership team will continue coordinating discovery, expert development, and trial preparation on behalf of thousands of women pursuing claims that chemical hair relaxers caused cancer and other reproductive injuries.

The reappointments come as the court prepares a group of cases for bellwether trial proceedings.

Judge Mary Rowland previously selected a pool of cases for intensive discovery and trial preparation, with the goal of testing key liability, causation, and damages issues before representative juries.

According to recent status reports, the parties continue to dispute aspects of discovery and case preparation, even as deadlines approach for completion of fact discovery in the bellwether pool.

The outcomes of these early trials are expected to play a significant role in evaluating the strengths and weaknesses of claims alleging that endocrine-disrupting chemicals contained in hair relaxer products caused uterine cancer, endometrial cancer, ovarian cancer, and related injuries.

While the leadership reappointments do not directly affect the merits of any individual claim, they are an important procedural development as the litigation advances toward expert challenges, bellwether trials, and potential future settlement discussions.

The Hair Relaxer MDL added 197 cases between May and June, increasing from 11,526 to 11,723.

The continued growth follows ongoing discovery efforts and recent disputes over expert testimony as the parties prepare the litigation for future bellwether trials.

With nearly 12,000 pending cases, the Hair Relaxer MDL remains one of the largest active product liability proceedings in the federal court system.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Lawmakers are pushing for stricter regulation of chemicals in certain hair products linked to serious health risks, including uterine and ovarian cancers.

A newly proposed federal bill, known as the Healthy Hair Act, would ban formaldehyde and formaldehyde-releasing chemicals commonly found in hair straightening and smoothing products.

The push for this legislation comes amid increasing concern that these products, heavily marketed to Black and Latina women, may expose users and salon workers to carcinogens.

Formaldehyde is already classified as a cancer-causing chemical and has been linked to respiratory issues, reproductive harm, and certain cancers.

Thousands of lawsuits already allege that manufacturers failed to warn consumers about the long-term health risks associated with repeated use of chemical hair relaxers.

Plaintiffs claim companies knew or should have known about the dangers but continued to market the products as safe.

The bill also highlights growing frustration with delays at the FDA, which has missed deadlines to implement its own proposed rules on formaldehyde in hair products.

Lawmakers are now attempting to force action through legislation.

Consumer Reports testing found that all 23 hair dye products analyzed contained at least one potentially harmful chemical, including compounds linked to cancer, hormone disruption, and organ toxicity. Brands tested included L’Oréal Paris, Clairol, Revlon, and Naturtint.

The testing identified dichloromethane in all samples, a chemical classified as a probable carcinogen.

Six products contained toluene, and four contained the phthalate DEHP, which has been associated with endocrine disruption and reproductive health risks.

One product contained benzene, a known carcinogen linked to leukemia.

Several products also showed trace amounts of heavy metals such as arsenic, lead, and chromium.

All tested products emitted volatile organic compounds (VOCs), which can be inhaled during application and may contribute to cumulative health risks.

The Consumer Reports findings identify similar chemical classes in hair dyes, including phthalates and other compounds that may disrupt hormone function.

Scientific research cited in the report links repeated use of permanent hair dye to increased breast cancer risk and identifies higher risk levels associated with long-term use and darker dye formulations.

The National Institute of Environmental Health Sciences Sister Study reported that regular hair dye use was associated with a 9% increase in breast cancer risk, with higher rates observed among Black women who used permanent dyes frequently.

Additional data cited in the report found an association between combined use of hair dyes and hair relaxers and increased cancer risk.

The hair relaxer multidistrict litigation is moving toward early bellwether trials, with a structured selection process designed to identify representative cases involving ovarian, uterine, and endometrial cancer claims. 

The court initially required both sides to nominate cases, narrowing the pool to a smaller group for early trial testing.

The current schedule reflects a multi-phase process, including fact discovery, expert development, and dispositive motions, with the first federal bellwether trials not expected to begin until at least 2027. 

Earlier state-court trials may occur sooner, but MDL proceedings focus on developing a consistent evidentiary record before presenting claims to a jury.

These bellwether cases are intended to test key allegations that chemical hair relaxer products contain endocrine-disrupting chemicals linked to cancer and that manufacturers failed to adequately warn consumers of those risks. 

The outcomes will help evaluate causation, liability, and damages across thousands of pending claims.

The judge overseeing the Hair Relaxer MDL has rejected several proposed bellwether cases, finding that certain submissions were not appropriate for trial selection because they could distract from the central issues in the litigation.

The court took issue with cases involving additional complicating factors such as memory issues, mental health conditions, multiple cancer diagnoses, or overlapping claims in other mass torts.

The judge determined that these factors could shift focus away from the key questions surrounding alleged product risks and causation.

By excluding those cases, the court emphasized that bellwether trials should center on clear, representative claims that allow juries to evaluate the core allegations without unrelated complexities.

The goal is to ensure that early trials provide meaningful guidance on liability and damages based on the primary issues in dispute.

The judge ultimately selected a set of bellwether cases directly, reinforcing a more controlled approach to trial selection and focusing the litigation on claims most suitable for evaluating the underlying allegations about chemical hair products.

Colorado lawmakers are advancing legislation that would require warning labels on hair relaxers and synthetic hair products containing carcinogens or reproductive toxins, placing disclosure obligations at the center of consumer protection efforts.

The proposal comes amid extensive litigation in which more than 11,000 plaintiffs allege that chemical hair products caused cancers and that manufacturers failed to adequately warn consumers about those risks.

The bill focuses specifically on requiring clear labeling when products contain hazardous substances, rather than banning the products outright, reinforcing the importance of consumer awareness and informed use.

The legislative push reflects growing scrutiny over what information was available to consumers at the time of purchase and whether manufacturers sufficiently disclosed long-term health risks associated with repeated exposure to these chemicals.

Studies linking frequent use of hair relaxers to significantly increased cancer risk have intensified that scrutiny.

By mandating explicit warnings, the bill directly aligns with core allegations in current lawsuits that product risks were not adequately communicated, placing labeling and disclosure practices at the forefront of ongoing claims involving chemical hair products.

The Hair Relaxer MDL decreased by 69 cases between March and April, moving from 11,440 to 11,371.

The court continues to manage coordinated discovery and pretrial scheduling, with no new court activity reported during the month.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Attorneys involved in the growing Hair Relaxer Lawsuits will soon nominate representative claims for the first bellwether trials, marking a significant step in federal litigation over allegations that chemical hair straighteners increased the risk of reproductive cancers.

The bellwether selection process will help the court evaluate how juries respond to scientific evidence linking hair relaxer products to uterine cancer, endometrial cancer, and ovarian cancer.

Judge Rowland previously directed the parties to identify a pool of 32 representative lawsuits that could serve as potential bellwether trial candidates.

Bellwether trials are early test trials used in complex litigation to evaluate how juries may respond to evidence that will likely appear in many cases across the litigation.

Fact discovery for the initial bellwether pool is expected to conclude March 18.

The federal court overseeing Hair Relaxer Lawsuits has moved the litigation into the next procedural stage as disputes continue over expert testimony and corporate depositions. 

A March 9 status hearing focused on preparation for the upcoming expert witness phase.

Expert testimony plays a central role in product liability litigation involving alleged chemical exposure and cancer risks.

Courts evaluate expert testimony through Daubert motions, which are legal challenges seeking to exclude expert opinions lacking reliable scientific support.

Judge Rowland established briefing limits for the Daubert phase of the Hair Relaxer Lawsuits.

Defendants may file up to 100 pages challenging the testimony of ten expert witnesses retained by plaintiffs.

Plaintiffs may respond with a single 100-page brief or submit ten separate responses limited to ten pages each.

Defendants will receive an additional 50 pages for reply briefing.

A separate dispute has developed regarding corporate depositions. 

Plaintiffs seek sworn testimony from corporate representatives regarding marketing practices, product labeling, and warnings connected to specific plaintiffs and geographic markets.

Corporate depositions require a company to designate a representative who provides testimony on behalf of the corporation.

Plaintiffs argue that testimony can clarify internal knowledge about product safety, marketing decisions, and communication of potential risks.

Defense attorneys have proposed written stipulations instead of sworn depositions. 

Written stipulations would establish limited agreed-upon facts regarding marketing and labeling without requiring corporate representatives to testify.

Plaintiffs indicated that stipulations were considered after defense counsel suggested a global approach applicable to multiple bellwether plaintiffs.

Judge Rowland also addressed administrative deficiencies involving short-form complaints that were not properly served on defendants.

Short-form complaints allow plaintiffs to file standardized claims that reference a master complaint in MDL proceedings. 

The court plans to issue orders requiring correction of filing deficiencies.

Failure to comply may result in dismissal with prejudice, which permanently closes the affected claims.

A product liability lawsuit filed in Pennsylvania alleges that Just 5 Hair Dye caused a severe dermatologic reaction, resulting in chemical burns, lesions, abscesses, and hair loss after a consumer used the product as directed.

The complaint was filed by Karen Sow in the Philadelphia County Court of Common Pleas against Combe Incorporated, Pennsylvania CVS Pharmacy LLC, and an unidentified company involved in the product’s manufacturing or distribution.

Just 5 Hair Dye is manufactured by Combe Incorporated and marketed as a five-minute hair coloring product designed to gradually blend gray hair. The product is sold over the counter through major retailers and pharmacies, including CVS.

According to the complaint, Sow purchased Just 5 Hair Dye from a CVS location on Walnut Street in Philadelphia and applied the product on February 5, 2024.

The lawsuit states that Sow followed the instructions provided with the product by conducting a preliminary skin patch test before applying the dye to her scalp.

Patch testing is recommended by manufacturers to identify potential allergic reactions before full application.

Sow alleges the test showed no reaction, leading her to believe the product was safe to use.

The lawsuit alleges that after applying Just 5 Hair Dye to her scalp, Sow developed severe injuries including chemical burns, skin lesions, abscesses, and significant hair loss.

The complaint claims the product was defectively designed and manufactured and that product warnings failed to adequately disclose the risk of severe dermatologic reactions.

Hair dye bladder cancer lawsuits are legally separate from hair relaxer lawsuits.

Hair relaxer lawsuits involve chemical hair straightening products that plaintiffs allege caused uterine cancer, ovarian cancer, and other hormone-related injuries.

Hair dye lawsuits focus on chemical exposure associated with hair coloring products and involve different alleged injuries and product formulations.

The lawsuit also alleges the product entered the stream of commerce in an unreasonably dangerous condition without sufficient warnings regarding the possibility of serious scalp injuries, infections, and hair loss.

The Hair Relaxer litigation added 245 cases between February and March, increasing from 11,195 to 11,440.

The rise reflects continued filings alleging that chemical hair straightening products containing endocrine-disrupting substances increased the risk of uterine cancer, ovarian cancer, and other reproductive injuries.

The court continues to oversee coordinated discovery and pretrial proceedings within the federal multidistrict litigation.

The Hair Relaxer lawsuits focus on claims that manufacturers failed to warn consumers about long-term hormone-related cancer risks associated with repeated product use.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Colorado legislators have introduced the Hair Product Transparency and Safety Act, a bill that would require companies selling hair products in the state to disclose detailed information about chemical ingredients and potential health risks.

The proposed law aims to give consumers clearer insight into what is in products such as relaxers, straighteners, and other chemical hair treatments, and to address concerns about links between certain ingredients and serious health conditions.

Under the proposal, manufacturers would be required to provide ingredient lists and safety data, including information on known or potential carcinogens, reproductive toxins, and other chemicals of concern.

The bill reflects growing public health awareness and advocacy around hair product safety, particularly among communities disproportionately affected by exposure to certain cosmetic formulations.

Advocates argue that current labeling standards are insufficient and that consumers deserve transparent information to make informed choices.

Proponents of the legislation also contend that greater transparency will help prevent future harm by prompting manufacturers to reformulate products with safer ingredients.

The move comes amid widespread litigation and regulatory scrutiny over alleged health effects associated with some hair care products, and although the bill itself does not create liability for past harm, it signals legislative interest in enhancing consumer protections and safety oversight in the cosmetics market.

Colorado’s legislative process will determine whether the measure advances into law.

New research is adding another layer to the ongoing hair relaxer cancer litigation.

A February 2026 study by researchers at the Silent Spring Institute found that 41 out of 43 hair extension and braiding products tested contained hazardous chemicals, including substances linked to cancer, hormone disruption, and reproductive harm.

The study identified 169 chemicals across the sampled products, including flame retardants, pesticides, plastic stabilizers, and organotin compounds – some of which are associated with endocrine disruption and carcinogenicity.

Seventeen of the chemicals detected were linked to breast cancer, and multiple compounds were listed under California’s Proposition 65 as known to cause cancer or reproductive harm.

Researchers also found chemicals like dibutyl phthalate and DEHP (plasticizers tied to hormone interference), as well as benzyl chloride, which has been described as possibly carcinogenic.

Importantly, the study follows earlier findings that chemical hair relaxers are associated with significantly increased uterine cancer risk.

The Black Women’s Health Study reported a 50% increased risk of uterine cancer in frequent relaxer users, and a 2022 NIH study found that women who used straighteners more than four times per year had more than double the risk of developing uterine cancer.

While the current hair relaxer lawsuits primarily focus on endocrine-disrupting chemicals in chemical straighteners, this new data broadens the exposure picture.

Plaintiffs in hair relaxer cancer cases allege that long-term exposure to hormone-disrupting compounds increased their risk of uterine and other cancers.

The presence of similar endocrine-disrupting and carcinogenic compounds in extensions and braiding hair may reinforce arguments that women were exposed to overlapping chemical risks across multiple hair-care products.

Courts in the hair relaxer MDL continue to evaluate general causation evidence tying endocrine disruptors to hormone-driven cancers.

Studies identifying additional carcinogenic and hormone-altering chemicals in products heavily marketed to Black women may further support claims that certain communities faced cumulative chemical exposure risks over time.

As discovery progresses, chemical composition evidence – including what manufacturers knew about product contents and labeling – remains central to the litigation.

The federal multidistrict litigation involving chemical hair relaxer products continues to move forward, with the presiding judge issuing new deadlines to guide preparation for upcoming bellwether trials. Thousands of plaintiffs allege that long term use of hair relaxers and straightening products increased their risk of developing serious health conditions, including uterine, ovarian, and endometrial cancers.

Under the updated schedule, the parties are required to complete fact discovery for selected bellwether cases, followed by expert disclosures addressing general and specific causation.

The court has also set timelines for motions challenging the admissibility of scientific evidence, signaling a shift toward resolving key causation issues ahead of trial. These steps are intended to streamline the litigation and prepare a limited number of representative cases for jury trials that will test the strength of the claims.

The hair relaxer MDL remains one of the largest consumer product mass torts in the federal system, with filings continuing to grow. The newly established deadlines reflect the court’s effort to move the litigation out of its early procedural stages and toward bellwether trials that are expected to play a significant role in shaping future settlement discussions and the overall direction of the case.

The Hair Relaxer MDL added 211 cases between January and February, increasing from 10,984 to 11,195.

Filing activity increased compared to the prior month.

No major JPML actions or new docket developments were reported during the period.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The hair relaxer multidistrict litigation in the Northern District of Illinois has entered a critical stage as pretrial proceedings shift from case consolidation to substantive discovery and trial preparation.

The MDL now encompasses over 10,900 federal cases alleging that chemical hair relaxers caused cancers, including uterine, ovarian, and endometrial malignancies.

Plaintiffs and defendants are engaged in extensive fact and expert discovery, exchanging millions of documents and preparing for court‑scheduled sessions focused on scientific evidence.

The litigation is approaching a series of Daubert hearings to determine the admissibility of expert testimony, a development that will shape the presentation of general causation evidence in upcoming trials.

Bellwether cases are being selected to test legal theories and evidence, with the first federal trials expected in 2027.

Major manufacturers named in the litigation include L’Oréal, Revlon, SoftSheen‑Carson, ORS Olive Oil, Just for Me, Motions, and Cantu.

This phase of the MDL marks a transition from procedural growth to the evaluation of core scientific and legal issues.

Outcomes from expert challenges and early trials are likely to influence settlement discussions and the trajectory of remaining cases.

Plaintiffs’ counsel are focused on establishing causation and preparing compelling bellwether cases, while defendants continue to assert procedural and evidentiary defenses.

The hair relaxer cancer MDL is entering a pivotal, science-driven stage.

U.S. District Judge Mary Rowland has scheduled a Science Day beginning January 8, 2026, signaling the court’s focus on expert evidence and causation.

The docket has now surpassed 10,000 cases, and discovery is accelerating against major defendants, including L’Oréal and Strength of Nature.

Plaintiffs allege long-term use of chemical hair straighteners increased the risk of hormone-driven cancers, including uterine and ovarian cancer.

The outcome of Science Day is expected to shape the entire litigation.

The court will closely examine epidemiological studies and expert opinions linking relaxer chemicals to cancer risk.

How the judge views this emerging science will determine whether the cases move toward bellwether trials or stall at the stage of expert admissibility.

What comes next is likely a series of major Daubert challenges.

These rulings will decide whether plaintiffs’ experts can testify. If the experts survive, bellwether trials could follow soon after.

If they do not, the MDL could face delays similar to other mass torts that failed at the causation stage.

The litigation also carries broader significance.

Plaintiffs point to decades of aggressive marketing of relaxers to Black women, which continues to influence public scrutiny and legal strategy.

As the science phase unfolds, the hair relaxer MDL is approaching a make-or-break moment.

An advocacy organization has reported that the U.S. Food and Drug Administration failed to meet a self-imposed deadline to prohibit the use of formaldehyde in hair straightening products, despite longstanding scientific evidence linking formaldehyde exposure to cancer and other serious health effects.

The group says the delay leaves consumers exposed to a known hazard in chemical hair relaxers and straighteners, products already at the center of extensive litigation alleging they can cause uterine cancer, reproductive harm, and other injuries.

Critics argue that by missing this regulatory deadline, the FDA has not adequately protected public health, potentially leaving manufacturers free to market and distribute products containing formaldehyde without meaningful restriction.

This regulatory gap may affect ongoing and future product liability claims, where plaintiffs claim that unsafe chemicals in cosmetic products caused long-term harm and allege both manufacturer and regulatory failures to warn or act.

Science Day at the Hair Relaxer MDL starts this week, nearly three years after the JPML consolidated the litigation in February 2023.

With over 10,000 lawsuits pending, both sides will now present their scientific and factual frameworks to the court for the first time in a consolidated setting.

During Science Day, plaintiffs and defendants are expected to discuss general causation issues and important scientific disputes that will influence the scope of expert discovery.

The presentations aim to inform the court before rulings that could decide which claims move forward to bellwether trials.

The upcoming major deadline in the litigation is the conclusion of case-specific discovery in February 2026.

Considering the number of defendants, the range of alleged injuries, and the overall complexity of the MDL, the court has continued to advance the case on an aggressive schedule as it moves into the expert phase.

The Hair Relaxer MDL added 140 cases between December and January, increasing from 10,844 to 10,984.

Filing activity continues at a steady pace following prior consolidation.

No significant JPML actions or new docket developments were reported during the month.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

In ongoing hair relaxer litigation, manufacturers are now asserting that plaintiffs failed to preserve and produce critical evidence needed to support their claims that long-term use of chemical hair straighteners causes uterine cancer and other harms.

The defendants contend that plaintiffs’ attorneys did not retain or timely disclose documents and electronic data that could demonstrate how products were used, frequency of application, and other factors relevant to exposure and risk.

According to filings, some plaintiffs allegedly did not keep original packaging, purchase records, or contemporaneous notes about product use, and failed to preserve text messages and other communications that might shed light on their exposure histories.

Manufacturers argue this lack of foundational evidence undermines the reliability of plaintiffs’ claims and may justify sanctions or exclusion of certain testimony at summary judgment or trial.

If courts find that plaintiffs’ discovery failures were unreasonable or prejudicial, judges may limit expert testimony, bar specific evidence, or impose cost-shifting sanctions.

These developments could shape the trajectory of hair relaxer claims nationally by enforcing the evidentiary standards necessary to link product exposure to alleged injuries.

The Hair Relaxer MDL added 121 cases between November and December, bringing the total to 10,844.

This follows steady monthly increases throughout 2024.

Plaintiffs continue to allege that chemical hair straightening products have been linked to uterine cancer and other hormone-related conditions, and that manufacturers failed to warn consumers.

The litigation remains active as discovery progresses. If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

California enacted the C.U.R.L. Act in 2025 to prohibit the manufacture and sale of hair relaxer products that contain endocrine-disrupting and carcinogenic ingredients.

The law phases in enforcement through 2030 and requires manufacturers to remove chemicals such as formaldehyde, formaldehyde-releasing preservatives, select parabens, phthalates including DBP and DEHP, and several PFAS-family ingredients.

Manufacturers must also register hair relaxer formulations with the state and verify compliance through laboratory testing overseen by the Department of Toxic Substances Control.

Noncompliance may lead to civil penalties, product seizures, and enforcement actions initiated by the California Attorney General.

Regulatory shifts at the federal level have stalled. FDA efforts to restrict formaldehyde in cosmetic products did not advance after an executive order issued in January 2025 paused pending federal regulations.

Hair Relaxer Lawsuits reference this regulatory gap when arguing that manufacturers failed to reformulate products even after federal agencies identified associations between key ingredients and elevated rates of uterine cancer, breast cancer, fibroids, and fertility complications.

According to NIH research published in 2022, women who frequently used chemical hair straighteners experienced more than double the risk of uterine cancer compared to non-users. Black women represent the largest consumer group using chemical relaxers from childhood through adulthood and continue to face the greatest documented exposure.

The federal multidistrict litigation (MDL) over hair relaxer products will be updated in court on November 6, 2025.

The MDL, coordinated in the Northern District of Illinois under Judge Mary Rowland, is organizing bellwether cases to test jury responses to evidence and expert testimony.

Plaintiffs have begun scheduling depositions for 32 potential bellwether trial candidates.

The Court set a March 2, 2026 deadline for general causation expert discovery, followed by Daubert hearings in April 2026 to determine admissibility of expert opinions.

State court filings continue alongside the federal MDL, with at least 400 cases in Illinois, 600 in Georgia, 25 in Pennsylvania, and others in New York, California, and Delaware.

Early trial outcomes are expected to influence settlement timing and amounts but will not be binding on other plaintiffs.

The number of filed cases in the Hair Relaxer lawsuit rose from 10,552 in October to 10,723 in November.

Plaintiffs continue to claim that long-term exposure to chemical hair straighteners is linked to uterine, endometrial, and ovarian cancer.

The steady growth in case filings reflects ongoing outreach and interest from individuals exposed to these products over many years.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A newly published study on PubMed Central is expanding concerns about the health risks linked to chemical hair straighteners.

While earlier litigation has focused primarily on reproductive cancers, such as uterine or ovarian cancer, this research identifies increased risks of breast, colorectal, and stomach cancers among long-term users of relaxers.

Researchers found elevated cancer rates among women who frequently used chemical straighteners, with the strongest correlations seen in Black women, the demographic most heavily targeted by relaxer marketing.

These findings suggest that the potential pool of affected plaintiffs could be broader than previously understood.

As the scientific basis for litigation grows, attorneys are urging potential claimants to preserve usage histories, medical records, and pathology reports.

The study’s release may also influence case screening criteria and bolster arguments around causation in ongoing hair relaxer lawsuits.

On October 28, 2025, the Georgia Supreme Court reinstated a previously dismissed lawsuit alleging a link between chemical hair relaxers and endometrial cancer.

The case, brought by Marcella Franklin, claims that her long-term use of Dark & Lovely, a L’Oréal-owned product, exposed her to endocrine-disrupting chemicals that contributed to her cancer.

The trial court had dismissed the case for lack of specific product linkage, but Georgia’s high court unanimously reversed that ruling.

The justices found that the lower court improperly evaluated the plaintiff’s expert evidence at a preliminary stage, when courts must view facts in the light most favorable to the plaintiff.

The ruling raises broader legal questions about whether manufacturers can be held accountable for products disproportionately marketed to specific racial groups, particularly when those products contain toxic, untested chemicals.

It also signals new momentum for hair relaxer cases filed in state courts, even as more than 8,000 cases continue to move through federal multidistrict litigation (MDL) in Chicago.

The Georgia Supreme Court has overturned a lower appellate court ruling that previously barred lawsuits alleging health problems linked to chemical hair relaxers.

The ruling allows plaintiff Kiara Burroughs to continue pursuing claims against L’Oréal and Strength of Nature, two major beauty care companies.

At issue was whether Burroughs’ lawsuits violated Georgia’s statute of repose, a state law that limits the time frame in which specific legal claims can be filed.

The defendants argued that Burroughs’ claims were time-barred because she began purchasing their products decades earlier: L’Oréal in 2003 and Strength of Nature in 1995.

The companies maintained that the 10-year deadline began with her first purchase, rendering her 2022 lawsuit untimely.

Burroughs countered that she continued buying and using the relaxers within the last 10 years.

The trial court initially agreed with her interpretation, ruling that each new sale of the product reset the time period under the statute of repose. The Georgia Court of Appeals later reversed that decision, dismissing the lawsuits.

According to 11Alive News, the Georgia Supreme Court reversed the appellate ruling, stating that Burroughs’ allegations that she purchased relaxer products within the 10-year window were sufficient to avoid dismissal at this stage.

The Court’s opinion, however, left open the possibility for future dismissal depending on whether the alleged health issues are proven to have resulted from products sold outside the 10 years.

Burroughs began using chemical hair relaxers at age six and continued for nearly 20 years before stopping in 2014. In 2018, she was diagnosed with uterine fibroids.

Four years later, she filed suit following the release of a medical study suggesting a potential link between long-term chemical relaxer use and uterine conditions.

The Hair Relaxer lawsuit experienced a decline between September and October, with the total number of cases dropping from 10,858 to 10,552.

This decrease of 306 cases is one of the more significant month-over-month reductions seen in active mass tort dockets.

The lawsuit involves claims that chemical hair straighteners have been linked to serious health risks such as uterine and ovarian cancer.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

At Friday’s MDL hearing, U.S. District Judge Mary Rowland began clearing inactive and noncompliant claims from the chemical hair relaxer docket, ruling on several defense motions tied to Case Management Order No. 9.

One case was dismissed with prejudice outright, while others were dismissed without prejudice but can be refiled by December 30, provided plaintiffs rejoin the MDL and submit completed fact sheets and authorizations.

One plaintiff has until October 30 to cure deficiencies.

Two additional plaintiffs must file status reports by tomorrow or face dismissal with prejudice, while another claim has already been dismissed for repeated failure to prosecute.

This move signals a push for a cleaner, more accurate case count ahead of global settlement talks.

While it may seem harsh, the court emphasized that eliminating unverified or stagnant claims strengthens the litigation overall and sharpens focus on legitimate injuries.

The federal hair relaxer cancer litigation continues to advance, with U.S. District Judge Mary Rowland setting key deadlines that will shape the future of nearly 11,000 lawsuits consolidated in a multidistrict litigation (MDL) in the Northern District of Illinois.

Plaintiffs allege that manufacturers of products such as Dark & Lovely and Just for Me failed to warn consumers that long-term use of chemical hair straighteners may increase the risk of uterine, ovarian, and endometrial cancers, claims supported by scientific studies published about three years ago.

During a September 4 status conference, Judge Rowland granted plaintiffs additional time for expert disclosures and ordered that all expert discovery close by March 2, 2026, with Daubert (Rule 702) motions challenging the admissibility of expert testimony due by April 1, 2026.

These motions will test whether plaintiffs’ experts can present scientifically reliable opinions on the link between hair relaxer chemicals and cancer.

The outcome of these hearings will be pivotal: if the experts’ testimony is excluded, many claims may fail; if admitted, the litigation will proceed toward bellwether trials using a group of 32 representative cases now in discovery.

Although the initial trial results will not be binding on other claims, they are expected to heavily influence potential settlement discussions and the overall trajectory of this rapidly expanding litigation.

The hair relaxer litigation continues to expand.

According to the latest filings, 10,858 lawsuits are pending in the multidistrict litigation (MDL) as of September.

This reflects an increase from 10,567 cases reported in August, adding nearly 300 new filings in a single month.

The lawsuits, centralized in the U.S. District Court for the Northern District of Illinois, involve claims that long-term use of chemical hair relaxer products increases the risk of uterine cancer, ovarian cancer, and other serious health conditions.

Plaintiffs argue that manufacturers failed to adequately warn about the potential dangers associated with these products.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer MDL increased to 10,567 cases between July and August, up from 10,404 in July.

More women continue to file claims linking chemical hair straighteners to uterine cancer and other serious health risks.

Discovery remains active, with parties exchanging documents and expert reports.

The steady growth in filings reflects sustained claimant interest as litigation progresses toward key procedural milestones.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Revlon’s attempt to subpoena internal NIH documents related to hair relaxer cancer studies has been rejected by Judge Mary Rowland.

The company sought access not only to raw data but also to work papers, drafts, and communications between NIH scientists and plaintiffs’ attorneys.

Revlon hoped to challenge the credibility of the research underpinning thousands of claims in the ongoing multidistrict litigation (MDL).

However, the court sided with the NIH, which invoked the deliberative process privilege.

Judge Rowland agreed, noting that Revlon failed to show a compelling need for the internal documents and emphasizing the NIH’s status as a non-party.

The judge ruled that potential financial harm to Revlon was not a sufficient reason to override this protection.

This outcome favors plaintiffs, as it preserves the central role of published scientific evidence in establishing causation and shields federal agencies from discovery tactics that could undermine the litigation process.

It also highlights the court’s reluctance to draw non-party institutions into the MDL without clear justification.

Revlon remains in bankruptcy, with its Chapter 11 plan approved in early 2023.

California state court is now coordinating a growing line of hair dye bladder cancer lawsuits brought by salon professionals who allege long-term occupational exposure to professional coloring products increased their risk of bladder cancer.

At least 15 cases have been filed (one lead case plus more than a dozen related claims) and they have been centralized before a single judge for coordinated pretrial management.

An initial status conference, originally set for August, was accelerated to July 21, 2025, signaling the court’s intent to move the docket efficiently.

Plaintiffs say professional hair dyes were marketed as safe, yet routine multi-day exposure—by skin contact and inhalation during mixing and application—can substantially elevate bladder cancer risk even when gloves and standard precautions are used.

Salon work over decades compounds cumulative exposure, making hairdressers and colorists a key risk group.

Named defendants include major cosmetic manufacturers associated with professional dye brands.

The court will address preservation of evidence, protective orders, and when to lift an existing stay. Parties also expect discussion of an early bellwether structure, with the lead case positioned to test warnings, exposure science, and causation theories common to all filings.

Bellwether outcomes would guide negotiations and could frame any future settlement program for similarly situated salon workers nationwide.

How This Differs From Hair Relaxer Cancer Litigation: These cases involve alleged bladder cancer risks tied to chemical dyes used in professional salon settings—not the uterine, ovarian, or endometrial cancer claims driving the separate federal hair relaxer MDL.

Still, both proceedings center on long-term exposure to beauty-industry chemicals, manufacturer knowledge, and failure-to-warn theories, so rulings on discovery scope, expert standards, and warning adequacy in one docket may prove informative to the other.

A new peer-reviewed study published on July 1 in Cancer Epidemiology, Biomarkers & Prevention predicts that uterine cancer deaths will nearly double by 2050, with Black women expected to see the highest increase.

Mortality rates for Black women are expected to increase by nearly 98%, reaching 27.9 deaths per 100,000, compared to 11.2 per 100,000 among white women.

This increasing disparity is caused by more aggressive tumor types, later-stage diagnoses, and obstacles to healthcare.

Although the study doesn’t pinpoint a single cause, researchers emphasize hormone-disrupting chemicals in hair relaxers as a possible factor, aligning with a 2022 NIEHS study that connected frequent hair straightener use to a 2.5-fold increased risk of uterine cancer.

Black women were disproportionately represented among high-frequency users, although the increased cancer risk did not vary by race.

These developments happen as lawsuits increase against manufacturers like L’Oréal and SoftSheen-Carson.

Plaintiffs claim that the companies failed to warn users (many of whom began using relaxers early in childhood) about the cancer risks associated with long-term exposure.

The cases have been consolidated into a federal MDL in the Northern District of Illinois.

The federal judge overseeing the growing multidistrict litigation (MDL) against hair relaxer manufacturers has scheduled a “Science Day” for January 8, 2026, to review scientific evidence regarding alleged links between chemical straighteners and reproductive cancers.

More than 12,000 lawsuits have been filed in recent years, with plaintiffs alleging long-term use of hair relaxers like Dark and Lovely, Just for Me, and ORS Olive Oil contributed to the development of uterine, ovarian, or endometrial cancer.

The lawsuits accuse manufacturers, including L’Oreal and Revlon, of failing to warn users—primarily Black women—of the risks tied to repeated chemical exposure.

Science Day will allow both plaintiffs and defendants two hours each to present non-adversarial scientific overviews intended to inform the court.

While the presentations are not evidence and won’t be subject to cross-examination, they are expected to shape future rulings on expert testimony and admissibility standards.

The proceedings come ahead of scheduled bellwether trials, which will begin with a discovery pool of 32 selected cases.

These early trials aim to gauge jury reactions and could influence potential settlement negotiations.

The Hair Relaxer MDL reached 10,404 total cases in July, increasing from 10,317 in June.

Although the pace of filings has slowed, hundreds of new claims continue to be added each month.

Plaintiffs allege that prolonged exposure to chemical hair straighteners led to uterine cancer, endometriosis, and other reproductive health issues.

Discovery remains ongoing as both sides prepare for upcoming bellwether proceedings.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The MDL Court has scheduled Science Day in the Hair Relaxer litigation for January 8, 2026.

Each side will have two hours to present relevant scientific and medical information related to the case.

Judges from parallel state court proceedings have also been invited to participate.

Science Day is a crucial pretrial event aimed at helping the Court understand complex technical issues before reviewing expert challenges or motions.

Whether the case moves forward to Science Day or settles earlier remains uncertain.

Judge Mary Rowland has dismissed the only case in the hair relaxer MDL that named Walgreens as a defendant.

The lawsuit, filed on behalf of a woman who died from uterine cancer, referenced a single 2010 purchase of hair relaxer products from Walgreens but provided no evidence that the retailer was aware of any cancer risk.

The court determined that the complaint was too vague and lacked factual support.

Claims of breach of warranty and unjust enrichment failed to demonstrate any clear link between Walgreens’s actions and the alleged harm.

Attorneys in the MDL had already stopped pursuing Walgreens as a viable defendant.

The Philadelphia Court of Common Pleas has formally established a mass tort program for state-level hair relaxer lawsuits.

Approximately 25 cases have been included in the coordinated docket, now overseen by the court’s Complex Litigation Center.

The consolidation is intended to streamline pretrial procedures and discovery for plaintiffs alleging injuries from chemical hair relaxer products.

These claims center on long-term exposure to endocrine-disrupting chemicals and the alleged failure of manufacturers to warn consumers of associated health risks.

Philadelphia joins other jurisdictions managing coordinated state proceedings, including Georgia and New York.

The federal multidistrict litigation (MDL 3060) continues to progress in the Northern District of Illinois, where hundreds of similar cases are pending.

New York State is taking decisive action to address health risks associated with chemical hair relaxers.

On June 5, 2025, the State Senate passed Bill S6723, which mandates clear warning labels on hair relaxer products containing chemicals identified as carcinogens or reproductive toxicants.

Provisions of the Bill include:

• Mandatory Warning Labels: Products must display warnings such as:

• • “This product contains a chemical known to cause cancer”
  • “This product contains a chemical known to cause birth defects or other reproductive harm”
  • “This product contains chemicals known to cause cancer and birth defects or other reproductive harm”
• Label Specifications: Warnings must be printed in a font no smaller than 12-point and be clearly visible on the product packaging.
• Enforcement and Penalties: The New York Attorney General is authorized to enforce compliance. Violations may result in injunctions and civil penalties of up to $250 per unit for a first offense and $500 per unit for subsequent offenses.

This legislative move comes amid growing concerns over the health impacts of hair relaxers, particularly among Black women.

Studies have linked prolonged use of these products to increased risks of hormone-sensitive cancers.

In response, numerous lawsuits have been filed against manufacturers, alleging failure to warn consumers about these risks.

The bill now awaits further action in the Assembly.

If enacted, it will take effect 18 months after becoming law, providing manufacturers time to comply with the new labeling requirements.

On June 10, 2025, Judge Mary M. Rowland ordered defendants in the Hair Relaxer MDL (MDL No. 3060) to select a replacement bellwether case after one of the original trial plaintiffs voluntarily dismissed her claim.

The new bellwether must be chosen by July 1, 2025.

The dismissal and substitution will not alter the overall timeline for bellwether proceedings. Judge Rowland confirmed that current discovery and pretrial deadlines remain in place.

This includes the close of expert discovery on general causation scheduled for early 2026.

The selected bellwether trials are intended to serve as representative cases to test the viability of claims linking chemical hair relaxers to uterine, endometrial, and ovarian cancers.

Outcomes from these trials may influence future settlement talks and litigation strategy.

The MDL, centralized in the U.S. District Court for the Northern District of Illinois, includes thousands of claims filed by women who allege that prolonged use of hair relaxer products manufactured by L’Oréal, SoftSheen-Carson, and others caused their hormone-related cancers.

The first bellwether trials are expected to begin in late 2026 or early 2027.

The Hair Relaxer MDL grew by 381 new cases between May and June, pushing the total to 10,317.

The increase follows continued outreach from firms representing clients who developed cancer after years of using chemical straighteners.

Many of the new filings include pathology reports and detailed product use histories dating back to childhood.

Plaintiffs are pressing for the inclusion of additional manufacturers and brands in the discovery process, citing patterns in exposure timelines and shared chemical ingredients across multiple product lines.

Early case vetting is focusing on hormone-sensitive cancer diagnoses and long-term product use.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A newly published peer-reviewed study has added to growing concerns surrounding chemical exposure from personal care products, specifically those marketed to Black women and Latinas.

Researchers found that over half of the commonly used items—including lotions, shampoos, and soaps—contained formaldehyde or formaldehyde-releasing preservatives, which are linked to serious health risks including cancer.

The Taking Stock study, which evaluated the daily product use of 70 women in South Los Angeles, identified DMDM hydantoin as the most frequent formaldehyde-releasing chemical.

Other releasers included diazolidinyl urea, imidazolidinyl urea, and quaternium-15, all of which are difficult to identify on ingredient labels and are still widely used despite their known risks.

This research underscores longstanding concerns raised by the Environmental Working Group (EWG), which has repeatedly warned that products marketed to Black women disproportionately contain hazardous ingredients.

Formaldehyde exposure has been specifically linked to professional salon treatments such as hair straighteners and relaxers—products now central to hundreds of hair relaxer cancer lawsuits.

Plaintiffs in these lawsuits allege that chronic exposure to formaldehyde and hormone-disrupting chemicals in chemical hair straighteners caused uterine cancer, breast cancer, and other reproductive health conditions.

The new findings offer fresh evidence supporting these claims, highlighting how systemic chemical exposure is persistent.

While some states like California, Maryland, and Washington have taken steps to ban formaldehyde in cosmetics, there is still no federal ban in place.

Advocacy groups, including EWG, continue to push the FDA to prohibit the use of formaldehyde in all hair-straightening products.

32 Hair Relaxer Lawsuits have been selected for bellwether discovery.

The bellwether process will help shape the trajectory of over 12,000 related claims consolidated in federal court.

The lawsuits selected represent claims from women diagnosed with hormone-related cancers following regular use of chemical hair relaxers, including popular brands like Dark & Lovely, Just for Me, Optimum, and ORS Olive Oil.

Plaintiffs argue that the manufacturers failed to adequately warn consumers about the long-term risks of endocrine-disrupting chemicals present in their products, which have been marketed for decades primarily to African American women.

As part of the MDL’s bellwether process, both sides initially selected 20 representative cases, with each side striking four from the opposing party’s list.

The final pool of 32 lawsuits will undergo specific case discovery and preparation over the next two years.

According to a recent joint status report, fact discovery is expected to be completed by February 16, 2026, and general causation discovery will conclude by March 2, 2026.

Daubert motions challenging the admissibility of expert testimony are due by May 15, 2026.

Judge Rowland will select three cases for a bellwether trial by February 23, 2026; however, based on the current timeline, the first trial is not expected to begin until mid-2027.

The Hair Relaxer lawsuit involves claims that prolonged use of chemical hair relaxers and straighteners has led to serious health conditions, including uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers—especially women of color—about the risks associated with regular use of these products.

No new cases were added to the Hair Relaxer MDL in the past month.

The total number of filings remains at 9,936, reflecting a pause in new additions during this period.

Despite the halt in filings, the litigation remains active as plaintiffs continue to pursue justice for injuries linked to endocrine-disrupting chemicals found in hair relaxers.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer multidistrict litigation (MDL), currently encompassing nearly 10,000 pending cases, is entering a critical phase in the selection of bellwether trial cases.

By early next week, both plaintiffs and defendants are set to exchange 20 instances each, totaling 40, for preliminary bellwether consideration.

Each side will then be allowed to strike four cases, removing those they perceive as most challenging.

This strike process will narrow the pool to 32 instances for detailed case workup.

Over the next year, these 32 cases will undergo individual discovery, including the submission of expert reports.

This stage is expected to conclude by the end of 2025.

Subsequently, the field will be further reduced to 10 bellwether trial cases by early 2026.

While this structured timeline provides a clear pathway toward trial, prospects for a global settlement in 2025 remain uncertain.

Though some remain cautiously hopeful, the prevailing sentiment suggests it is unlikely under the current schedule.

This update underscores the central role trials play in driving resolution within mass tort litigation and highlights the ongoing momentum in the Hair Relaxer multidistrict litigation (MDL).

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer Lawsuit saw a slight increase in filings from March to April 2025.

In March, there were 9,788 total Hair Relaxer Lawsuits pending.

By April, this number had risen to 9,936, an increase of 148 new cases.

This uptick signals a continuing momentum in the multidistrict litigation involving chemical hair relaxers, which have been linked to significant health risks, including an increased risk of certain cancers.

Individuals who have used hair relaxer products and suffered adverse health effects are increasingly seeking legal recourse, joining the growing body of plaintiffs pursuing justice.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A Virginia woman has joined the growing number of plaintiffs alleging that long-term use of chemical hair relaxers caused her to develop reproductive cancers.

A lawsuit filed on March 20 in the Northern District of Illinois names L’Oreal, Revlon, and Softsheen-Carson as defendants.

The plaintiff claims her diagnoses of uterine and endometrial cancer in May 2023 resulted from decades of exposure to harmful chemicals in popular products like Optimum Relaxer, Olive Oil Relaxer, and Cream of Nature No Lye Relaxer.

The complaint will join more than 6,500 hair relaxer lawsuits already centralized in a federal multidistrict litigation (MDL) overseen by Judge Mary Rowland in Chicago.

These lawsuits largely stem from a pivotal 2022 NIH study linking chemical hair relaxers to a heightened risk of uterine cancer.

Additional research has connected long-term use to endometrial and ovarian cancer.

Like many plaintiffs, this case alleges that these products contain endocrine-disrupting chemicals and that the manufacturers failed to warn consumers—particularly Black women, who have been disproportionately targeted in marketing campaigns.

Earlier this month, Judge Rowland established the bellwether trial selection process.

The first trials are not expected to begin until at least 2027, but they will play a key role in shaping future settlement talks.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Concerns over the health risks associated with chemical hair relaxers continue to drive a shift away from these products, especially as studies increasingly link them to severe health conditions such as uterine and ovarian cancers.

For decades, Black women have been disproportionately targeted by advertisements for chemical relaxers, which many used to straighten their hair.

Now, thousands of women are involved in a growing legal battle against cosmetic manufacturers, claiming their products caused life-threatening health issues.

The most significant legal development in these lawsuits involves the establishment of a bellwether trial schedule for the multidistrict litigation (MDL) surrounding hair relaxers.

The MDL consolidates over 6,500 product liability lawsuits filed by women diagnosed with uterine cancer, ovarian cancer, and endometrial cancer after using chemical relaxers such as Optimum, Dark & Lovely, and Just For Me.

Hair Relaxer Lawsuits claim that these products, which contained endocrine-disrupting chemicals, caused these cancers due to long-term use of hair straighteners.

The bellwether trials, which will be used to gauge the potential success of other cases in the MDL, have been scheduled to begin in mid-2027.

A recent order from U.S. District Judge Mary Rowland outlines the selection process for 40 potential bellwether cases.

These will include claims from women diagnosed with cancers linked to hair relaxer use.

The judge also outlined a detailed timeline for discovery and pretrial motions, with the first trials not expected until 2027.

The MDL’s development comes after studies like the “Sister Study,” which found that regular use of chemical relaxers could double the risk of uterine cancer.

As the legal proceedings unfold, the potential for settlements increases, but the long timeline suggests that many women seeking justice for their health issues may still face years of litigation.

If the bellwether trials do not result in a global resolution, individual trials may begin in various U.S. District Courts, extending the litigation process.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A new Hair Relaxer Lawsuit has been filed on behalf of a Mississippi woman who died from endometrial cancer after using chemical straighteners for 16 years.

The lawsuit, filed on February 27, 2025, in the U.S. District Court for the Northern District of Illinois, names several major brands including L’Oreal, Softsheen-Carson, Dabur International, and others.

It alleges that exposure to chemicals in products like Just for Me, Dark & Lovely, and ORS Olive Oil led to Swearengen’s fatal cancer.

This lawsuit is part of over 6,500 claims accusing hair relaxer manufacturers of causing uterine, ovarian, and endometrial cancers. 

The Hair Relaxer Cancer Lawsuit stems from studies linking these products to cancer risk, with plaintiffs claiming manufacturers failed to warn consumers about potential health risks. 

Cases are now centralized in a multidistrict litigation (MDL) overseen by Judge Mary Rowland.

Bellwether trials focusing on uterine, endometrial, and ovarian cancer will help guide the settlement process in the coming years.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer Lawsuit involves claims that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers such as uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers of the long-term health risks associated with these products.

In February, 9,863 Hair Relaxer Lawsuits were pending in the MDL.

This number has decreased slightly to 9,788 in March, a reduction of 75 cases.

This decline may be due to case consolidations or procedural adjustments within the litigation.

Exposure to harmful chemicals in hair relaxers has been linked to serious health conditions, including hormone-related cancers, significantly impacting users’ well-being.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A new investigation by Consumer Reports has found that synthetic braiding hair may expose users to harmful chemicals, including carcinogens and heavy metals like lead.

The report tested 10 popular brands of synthetic braiding hair and found that all contained volatile organic compounds (VOCs) and at least six toxic chemicals.

Key findings include:

• Carcinogens detected in 100% of tested products, with benzene, methylene chloride, and styrene among the most common.
• Lead found in 9 out of 10 products, exceeding safe exposure limits.
• VOCs released when heated, including acetone and toluene, which can cause respiratory irritation, headaches, and long-term health effects.
• Potential skin reactions, including rashes, itching, and irritation, reported by users.

The report raises concerns about the safety of synthetic hair products widely used by Black women, as these chemicals could be absorbed through the scalp, inhaled, or ingested through hand-to-mouth contact.

Experts are calling for greater transparency and regulation of synthetic hair products.

The FDA has yet to take action, but consumer advocacy groups are urging policymakers to enforce stricter safety standards.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Hair stylists and salon professionals are increasingly filing lawsuits against hair dye manufacturers, claiming the companies failed to warn about the cancer risks associated with long-term exposure to chemicals in hair coloring products.

Growing research has linked these chemicals, including those in permanent, semi-permanent, and temporary dyes, to bladder and breast cancer.

Studies have shown that salon workers are at a significantly higher risk due to frequent and prolonged exposure to carcinogenic substances like aromatic amines, formaldehyde, and resorcinol.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A former hairstylist has filed a lawsuit against L’Oréal and 10 other beauty companies, alleging that repeated exposure to carcinogenic chemicals in hair dyes caused his bladder cancer.

The lawsuit, filed in Los Angeles, claims that manufacturers failed to warn about the risks associated with chemicals like 4-aminobiphenyl (4-ABP), a known carcinogen still found in some hair dyes.

Decades of occupational studies have linked long-term exposure to hair dyes with an increased risk of bladder cancer among hairstylists.

Research has also raised concerns about the potential health risks for frequent consumers of permanent hair dye, particularly for women of color using darker shades.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer MDL has entered a critical phase as both sides begin selecting 40 bellwether cases.

Bellwether trials are test cases in multidistrict litigation (MDL) used to gauge how juries might respond to evidence and arguments in similar lawsuits.

Their outcomes can influence settlement negotiations and the broader direction of the litigation.

Each side will choose 20 cases and submit a joint stipulation to the court by May 9, 2025.

Once selected, individual case work will last until February 2026, followed by another year of expert analysis.

The types of cancer chosen for these bellwether cases will be key in shaping the litigation, helping identify the strongest claims.

Given this timeline, a settlement in 2025 appears unlikely as litigation moves through discovery and expert evaluation.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer Lawsuit involves claims that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers such as uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers of the long-term health risks associated with these products.

9,819 cases were pending in the Hair Relaxer MDL at the beginning of the year, increasing to 9,863 in February, with 44 new claims added.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The proposed FDA ban on formaldehyde in hair relaxer products, linked to increased cancer risks, faces uncertainty following regulatory freezes under the new presidential administration.

Initially proposed in October 2023, the ban aimed to eliminate formaldehyde and its byproducts from hair relaxers sold in the U.S.

Despite an expected April 2024 finalization, delays under the previous administration left formaldehyde-containing products on the market.

NBC News reports that recent administrative actions, including halting new regulations, may Ïfurther jeopardize the ban.

However, states like California, Maryland, and Washington have enacted formaldehyde bans in hair care products.

Formaldehyde, commonly found in consumer products, has been linked to cancers such as uterine and ovarian cancer, as well as respiratory and reproductive issues.

Recent lawsuits allege manufacturers like L’Oréal and Revlon knowingly sold dangerous products, including Dark & Lovely and Just for Me, which contain endocrine-disrupting chemicals.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

On December 30, 2024, a resident of Neptune, New Jersey, filed a lawsuit against Strength of Nature, LLC, and Godrej SON Holdings, Inc. in the U.S. District Court for the Northern District of Illinois.

The plaintiff alleges that prolonged use of the defendants’ hair relaxer products caused her uterine cancer, diagnosed in July 2016.

The case is part of MDL No. 3060, which consolidates numerous similar claims against hair relaxer manufacturers for failing to warn consumers about potential health risks.

The plaintiff claims the products were defectively designed and contained harmful chemicals linked to cancer.

Her lawsuit asserts causes of action from the MDL’s Master Long Form Complaint, including:

• Negligence
• Strict liability for design defects and failure to warn
• Breach of warranties under state law and the Magnuson-Moss Warranty Act
• Fraudulent misrepresentation and concealment
• Violation of consumer protection laws

The plaintiff specifically named the African Pride Olive Miracle Deep Conditioning No-Lye Relaxer among the products she used.

The plaintiff argues that the manufacturers failed to provide adequate warnings or safer alternatives despite knowing the risks.

The plaintiff seeks compensatory damages for her injuries and suffering, as well as punitive damages to deter future misconduct.

This case will be presided over by Judge Mary M. Rowland under Case ID: 1:24-cv-13330.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

The Hair Relaxer Lawsuit involves claims that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers such as uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers of the long-term health risks, particularly for women of color.

In December, 9,649 cases were pending in the Hair Relaxer MDL

The number of cases has risen to 9,819 in January 2025, adding 170 new claims.

This increase reflects growing awareness of the potential dangers associated with prolonged use of these products.

Exposure to the harmful chemicals in hair relaxers has been linked to significant health challenges, including hormone-related cancers, posing severe risks to users.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

New research from the European Journal of Obstetrics and Gynaecology and Reproductive Biology strengthens concerns over the harmful effects of chemicals in hair products, including dyes and chemical straighteners.

The 2024 study highlights potential links between these products and hormonal disruptions, as well as carcinogenic risks, with associations observed between the use of hair relaxers or dyes and breast and ovarian cancers.

The study points to chemicals such as aromatic amines, parabens, formaldehyde, resorcinol, and ammonia as culprits.

These substances can interfere with the body’s hormonal systems, mimic estrogen, and pose long-term health risks, including cancer.

Formaldehyde, often found in chemical straighteners, is particularly troubling due to its carcinogenic properties.

As lawsuits surrounding hair relaxer products continue, this research underscores the urgent need for consumer awareness and industry accountability.

Plaintiffs in the ongoing Hair Relaxer litigation argue that manufacturers failed to warn about these risks, despite evidence of the harmful effects of chemical exposure through the scalp.

This study may bolster claims in current Hair Relaxer Lawsuits, further emphasizing the potential health risks associated with these products.

As cases progress, the findings could have significant implications for consumer safety regulations and product liability standards.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Lawyers involved in the federal hair relaxer lawsuits have failed to reach an agreement on the bellwether trial process.

On December 13, U.S. District Judge Mary Rowland ordered both sides to submit competing proposals by January 3, 2025.

This decision impacts nearly 10,000 lawsuits centralized in the Northern District of Illinois as part of a multidistrict litigation (MDL).

The lawsuits allege that popular hair relaxer brands, including Dark & Lovely and Just For Me, failed to warn users about the cancer risks associated with their products.

Studies published in 2022 highlighted that women using these products had a significantly higher risk of uterine cancer and other illnesses linked to endocrine-disrupting chemicals.

Judge Rowland aims to establish a “bellwether” process, selecting 16 representative cases to proceed to trial.

These trials will test legal arguments and evidence common across cases, potentially influencing future settlement discussions.

The plaintiffs argue that delays in selecting bellwether cases stem from the defendants’ refusal to finalize their eight case selections, despite having months to review necessary documents.

The court plans to issue a comprehensive bellwether protocol, addressing trial selection, discovery timelines, and case preparations.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

Our attorneys have decades of experience securing compensation for people harmed by dangerous products.

A lawsuit has been filed against the manufacturers of Mielle Hair Oil, alleging that the product does not work as advertised and, in some cases, may cause hair loss.

The lawsuit focuses on Mielle Organics Rosemary Mint Scalp & Strengthening Hair Oil, which is marketed as a product that promotes hair growth, strengthens strands, and nourishes the scalp.

However, a Massachusetts woman, Georgina Gomes, claims that the manufacturers knew or should have known that the product’s ingredients could lead to hair loss for some users but failed to adequately disclose this risk.

The complaint, filed on November 21 in the U.S. District Court for the Northern District of Illinois, seeks damages from Mielle Organics and its parent company, Procter & Gamble.

Gomes alleges that had consumers been aware of the potential for hair loss, they would not have purchased the product.

She specifically claims that after buying and using the hair oil, she experienced hair loss instead of the promised strengthening effects.

The lawsuit contends that the manufacturers continued to produce and sell the product despite being aware of these risks.

The lawsuit seeks class action status for Gomes and other individuals who purchased Mielle Organics Rosemary Mint Scalp & Strengthening Hair Oil, with proposed subclasses for residents of certain states.

If successful, the lawsuit could lead to financial compensation and corrective actions against the manufacturers.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

Our attorneys have decades of experience securing compensation for people harmed by dangerous products.

We’re here to help.

The Hair Relaxer Cancer lawsuit involves claims that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers such as uterine and breast cancer.

Plaintiffs argue that manufacturers failed to warn consumers of the risks associated with long-term use of these products, especially those marketed toward women of color.

In November, 9,488 cases were filed, rising to 9,639 in December, with 151 new claims added.

Regular exposure to these chemicals has been linked to hormone-related cancers, causing significant health challenges for affected individuals.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

Our attorneys have decades of experience securing compensation for people harmed by dangerous products.

The litigation surrounding hair relaxers continues to expand, with nearly 9,500 lawsuits pending in federal courts and an additional 300 cases filed in state courts across Illinois, Georgia, New York, Pennsylvania, and Delaware.

Most Hair Relaxer Lawsuits are consolidated under a multidistrict litigation (MDL) in the Northern District of Illinois before Judge Mary Rowland.

Hair Relaxer Lawsuits allege that toxic chemicals in popular hair straighteners, such as Dark & Lovely, Just for Me, Optimum Care, and ORS Olive Oil, have caused uterine cancer, endometrial cancer, ovarian cancer, and other injuries.

Federal Litigation Developments include:

• Status Conference: Judge Rowland presided over a status conference to address key issues, including motions to dismiss, deposition protocols, and plans for selecting bellwether cases to represent the broader litigation.

• Discovery Process: The discovery phase, focused on evidence sharing relevant to all claims, will continue through most of 2025.

• Bellwether Trials: Early bellwether trials will be held following case-specific discovery, aiming to gauge jury responses to evidence and potentially influence settlement negotiations.

• Dismissals Without Prejudice: Claims involving injuries other than uterine, endometrial, or ovarian cancer have been dismissed without prejudice, allowing plaintiffs to refile if they develop one of these cancers in the future.

State Court Actions include:

• Cook County, Illinois: 145 cases are consolidated, with Judge Kathy M. Flanagan overseeing the trial calendar. Five cases may soon be scheduled for trial, with dates expected after a November 26 hearing.

• Other States: Georgia has 126 claims pending, Pennsylvania (26), New York (4), and Delaware (1).

The litigation’s primary focus remains on uterine cancer, endometrial cancer, and ovarian cancer.

Studies have shown a 156% increased risk of uterine cancer among women who regularly use hair relaxers.

Coordinated discovery and trials aim to build a robust foundation for future claims and settlements.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A growing number of women have filed lawsuits against hair relaxer manufacturers, claiming the products caused serious health issues, including uterine cancer, ovarian cancer, and endometrial cancer.

In response, the U.S. District Judge overseeing these cases has designated a Federal Magistrate Judge to manage discovery disputes and maintain the progression of these claims.

Over the next year, a series of case management conferences will address key issues, leading up to potential trial dates.

The hair relaxer litigation, initiated in 2022, stems from a study linking hair relaxer chemicals to a 156% increased risk of uterine cancer.

Over 9,500 lawsuits have been filed against well-known brands like Dark & Lovely and Just for Me, alleging that these companies failed to adequately warn consumers of potential risks posed by endocrine-disrupting chemicals in their products.

Judge Rowland has set specific discovery deadlines, requiring written discovery completion by February 2025 and oral discovery completion by September 2025.

Magistrate Judge Beth W. Jantz has been appointed to handle disputes that arise during this phase, but she cannot modify the set deadlines.

Case management conferences are scheduled monthly from November 2024 to December 2025 to track discovery progress.

Judge Rowland has directed the parties to propose bellwether trial plans.

If you or a loved one used chemical hair straighteners and subsequently developed cancer or other health problems, you may be eligible to file a Hair Relaxer Lawsuit.

Contact TorHoerman Law’s Hair Relaxer Lawyers for a free consultation.

You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and to get in touch with our Hair Relaxer Attorneys.

The Hair Relaxer Lawsuit involves claims that chemicals in hair relaxers and straighteners contain carcinogenic ingredients linked to cancer.

Plaintiffs allege that manufacturers failed to warn consumers about the cancer risks associated with prolonged use of these products, which are frequently marketed to women of color.

In October, 8,393 cases were filed under the Hair Relaxer and Hair Straightener lawsuit.

By November, the number has risen significantly to 9,488, an increase of 1,095 cases.

This sharp rise reflects growing public awareness about the health risks linked to these products and an increase in individuals seeking legal action.

The chemicals in these products, including endocrine-disrupting substances, are associated with hormone-related cancers, posing significant health risks to those using them regularly over extended periods.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

As the number of Hair Relaxer Lawsuits continues to rise, the federal court overseeing the litigation has extended the timeline for discovery into late 2025.

This discovery process includes written discovery set to be completed by February 28, 2025, and oral discovery to be finished by September 30, 2025.

The litigation, centralized under U.S. District Judge Mary Rowland in the Northern District of Illinois, involves claims that popular hair relaxer products, such as Dark & Lovely and Just for Me, may cause uterine cancer, endometrial cancer, ovarian cancer, and other health issues.

There are currently around 8,400 lawsuits pending in the Hair Relaxer MDL, all alleging that the manufacturers failed to provide adequate warnings about the cancer risks associated with regular use of chemical hair straighteners.

Hair Relaxer Lawsuits began to surface in late 2022 after a study reported a significant link between hair relaxers and uterine cancer, showing a 156% increased risk for women who used these products regularly.

In November 2023, Judge Rowland ordered both sides to submit trial plans for selecting representative cases for bellwether trials, a process that will help determine how juries might respond to these claims.

Although the parties have not yet agreed on key aspects of the bellwether trial process, the first cases are expected to go before juries in 2026 or later.

The outcome of these early trials could set the stage for settlement negotiations, potentially leading to hair relaxer settlements for women diagnosed with cancer linked to these products.

If you or a loved one used chemical hair straighteners and subsequently developed cancer or other health problems, you may be eligible to file a Hair Relaxer Lawsuit.

Contact TorHoerman Law’s Hair Relaxer Lawyers for a free consultation.

You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and to get in touch with our Hair Relaxer Attorneys.

The Hair Relaxer Lawsuit has encountered several critical motions and processes that could impact the trajectory of these cases.

Plaintiffs have filed a motion to dismiss non-cancer cases without prejudice, meaning these cases could be refiled later.

Additionally, plaintiffs have requested the court to enforce discovery orders against L’Oréal, targeting specific information disclosures.

Numerous defendants have filed dismissal motions, but these are expected to face significant challenges in gaining traction.

Efforts to establish a bellwether process are underway, which will set up representative cases for early trials. 

In terms of defendant-specific discovery, certain defendants, such as Strength of Nature and Namaste Laboratories, face motions concerning document production and protective orders.

Revlon has submitted a considerable amount of discovery material, although plaintiffs are actively reviewing the data for completeness.

Several “second-wave” defendants, including Advanced Beauty, John Paul Mitchell, and Wella Operations, have moved to dismiss claims against them.

Lastly, an amendment to Case Management Order 10 is being developed to streamline tracking and compliance.

This amendment will assist in managing plaintiff data, particularly for cases dismissed without prejudice, ensuring orderly re-filing if necessary.

If you or a loved one used chemical hair straighteners and subsequently developed cancer or other health problems, you may be eligible to file a Hair Relaxer Lawsuit.

Contact TorHoerman Law’s Hair Relaxer Lawyers for a free consultation.

You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and to get in touch with our Hair Relaxer Attorneys.

The Hair Straightener Cancer Lawsuit involves claims that the chemicals used in hair relaxers and straighteners contain carcinogenic ingredients that have been linked to an increased risk of developing certain cancers, including uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers about the potential cancer risks associated with long-term use of these products, which are particularly marketed toward women of color.

In September, the number of cases filed in the Hair Relaxer MDL was 8,489.

By October, the total number of cases has decreased to 8,393, reflecting a reduction of 96 filings.

This decrease in the number of Hair Relaxer Lawsuits may be related to the court not permitting certain diagnoses and medical monitoring cases to be added to the litigation.

In August, plaintiff’s attorneys requested that the court dismiss, without prejudice, all cases with non-cancer injuries.

The chemicals in hair relaxers, such as formaldehyde and other endocrine-disrupting substances, have been shown to affect hormone levels, which can contribute to the development of cancer.

Studies have found that frequent exposure to these chemicals increases the risk of hormone-related cancers, making this lawsuit particularly important for the many women who have used these products over extended periods.

If you or a loved one used chemical hair straighteners and subsequently developed cancer or uterine fibrosis, you may be eligible to file a Hair Relaxer Lawsuit.

Contact TorHoerman Law’s Hair Relaxer Lawyers for a free consultation.

You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and to get in touch with our Hair Relaxer Attorneys.

The ongoing Hair Relaxer multidistrict litigation (MDL), which consolidates over 8,500 cases, has narrowed its focus to claims involving ovarian, uterine, and endometrial cancers.

In a rare move for mass tort cases, plaintiff leadership has proactively sought to dismiss hundreds of unrelated claims.

However, despite these developments, experts are concerned that defendants are causing significant delays in the litigation by withholding key documents needed to complete general discovery.

The impact of these delays is hindering the case’s movement forward, leaving plaintiffs waiting for resolution.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly. 

The Hair Relaxer Litigation has experienced a notable increase in filings, rising from 7,946 in August to 8,489 in September.

Research has shown that certain chemicals found in hair relaxers and straighteners, such as formaldehyde and other endocrine-disrupting compounds, may increase the risk of developing cancers, including uterine and breast cancer.

These chemicals found in hair relaxers and straighteners  can cause cancer by interfering with the body’s hormonal balance.

Once in the body, these chemicals can mimic or block natural hormones, disrupting normal hormonal functions.

This disruption can lead to abnormal cell growth, particularly in hormone-sensitive tissues like the uterus and breasts.

Over time, these abnormal cells can develop into cancerous tumors.

Formaldehyde, in particular, is a known carcinogen and is directly linked to cancer in humans.

If you or a loved one used chemical hair straightening products and were subsequently diagnosed with uterine cancer, endometrial cancer, breast cancer, or another related health problem, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

Two U.S. Representatives, Ayanna Pressley of Massachusetts and Shontel Brown of Ohio, are pressing the Food and Drug Administration (FDA) for answers regarding the delay in proposing a ban on certain hair-straightening products containing formaldehyde, a chemical linked to increased cancer risks.

Their efforts are supported by Rep. Nydia Velazquez of New York, who joined them in sending a letter to FDA Commissioner Robert Califf.

The letter follows the FDA’s initial announcement in 2023 of a possible rule to ban these chemicals, primarily used in products targeting Black women.

The proposed rule’s target date has been postponed multiple times, from April to July, and now to September, prompting the Congresswoman’s request for an explanation.

Pressley emphasized that the delay could lead to further health risks for communities of color, particularly Black women, who have historically faced discrimination and health issues linked to hair straighteners.

This regulatory uncertainty comes as thousands of lawsuits have been filed against beauty companies, alleging that these products increased the risk of uterine and ovarian cancers and caused infertility.

These lawsuits claim that the manufacturers misrepresented the health impacts of their products, exposing consumers to harmful chemicals without adequate warning.

A 2022 study by the National Institutes of Health and a 2023 study by Boston University both found significant links between the use of chemical hair straighteners and an elevated risk of uterine cancer.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Relaxer Cancer Lawsuit involves claims against manufacturers of chemical hair straighteners and relaxers.

Plaintiffs allege that these products cause various cancers, including uterine and breast cancer, due to harmful chemicals.

In July, there were 8,192 filings pending in the Hair Relaxer Cancer lawsuit.

By August, this number decreased to 7,946 filings.

This decrease is likely due to cases being cut for certain injuries no longer being accepted or duplicate cases being identified.

The short form complaint, introduced this year, allows plaintiffs to file directly into the MDL, bypassing state courts.

This change may have resulted in some plaintiffs inadvertently creating duplicate cases.

Chemical hair straighteners and relaxers contain ingredients that have been linked to an increased risk of cancers such as uterine and breast cancer.

These chemicals may disrupt hormonal balances and lead to the development of cancerous cells, prompting many individuals to seek legal action against the manufacturers.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The US Food and Drug Administration (FDA) has failed to implement its planned ban on formaldehyde in hair relaxer products, missing its own April deadline.

This delay comes amid thousands of lawsuits claiming that hair relaxer products containing formaldehyde have caused cancer and other serious health concerns.

These lawsuits allege that popular hair relaxer products have led to cancer, particularly targeting women who used these products.

Plaintiffs lawyers for those suffering from the negative health effects of hair relaxer products expressed disappointment at the FDA’s delay.

According to a statement from the FDA, the proposed rule to ban formaldehyde remains a high priority and is still in the rulemaking process.

The FDA cited the need for thorough risk assessments, literature reviews, and inter-agency approvals as reasons for the delay.

The FDA’s semiannual agenda of upcoming regulations, which includes the proposed formaldehyde ban, outlines these steps.

As the litigation progresses, plaintiffs and their attorneys hope for stricter regulations and greater accountability in the production and marketing of hair relaxer products.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

Hair relaxer lawsuits highlight significant health risks, particularly affecting Black women.

Research by Dr. Tamarra James-Todd of Harvard reveals that chemicals in hair relaxers cause reproductive disorders and cancers.

These products contain endocrine-disrupting substances linked to early menstruation, uterine fibroids, preterm birth, infertility, and cancers.

Black women face a 28 percent higher breast cancer death rate than White women due to these issues.

Despite known dangers, hair relaxers remain inadequately regulated by the FDA.

Many products contain banned substances like formaldehyde, and 84 percent of toxic ingredients are not listed on packaging, leaving consumers unprotected.

Lawsuits allege manufacturers prioritize profits over safety, marketing dangerous products without proper warnings.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Straightener lawsuit involves claims that certain hair straightening products contain harmful chemicals linked to cancer.

This lawsuit seeks to hold manufacturers accountable for the health risks associated with these products.

In June, there were 8,170 Hair Straightener lawsuit filings.

By July, this number increased to 8,192, reflecting growing awareness of the dangers posed by these hair straightening products.

Hair straighteners contain toxic chemicals that can cause cancer by disrupting hormonal functions and damaging cellular DNA.

Prolonged exposure to these chemicals has led to serious health issues, prompting more individuals to join the Hair Straightener lawsuit.

The Hair Straightener lawsuit aims to hold manufacturers responsible for the harm caused by these dangerous products.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

In February 2023, a federal judge combined thousands of individual claims into a comprehensive multidistrict litigation concerning the adverse health effects associated with chemical hair relaxers.

Recent research, notably the 2022 Sister Study led by the National Institute of Environmental Health Sciences, has demonstrated a significant link between the frequent use of hair straightening chemicals and an increased risk of developing uterine cancer.

The issue at the core of these lawsuits is the alleged negligence by manufacturers in ensuring the safety of hair relaxer products, which contain endocrine-disrupting chemicals.

These substances have been linked to a range of serious reproductive health issues, including early puberty, infertility, and various types of cancer, which disproportionately affect Black women.

Despite these risks, the products have been minimally regulated in the United States, a stark contrast to stricter controls in regions like the European Union.

The consolidation of these lawsuits into multidistrict litigation aims to streamline the legal process, allowing for more efficient handling of the numerous cases that share common questions of fact concerning the alleged health risks of chemical hair relaxers.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Relaxer Cancer Lawsuit involves allegations that chemical hair straightening products cause various types of cancer.

The number of cases in the Hair Relaxer MDL decreased from 8,468 in May to 8,170 in June.

This reduction of 298 cases may be attributed to plaintiffs opting not to proceed with claims involving non-cancer injuries, focusing on the litigation more directly on cancer-related allegations.

Research indicates that the chemicals in hair relaxers can be absorbed through the scalp, potentially leading to an increased risk of cancer including uterine and breast cancers.

Frequent use of chemical hair relaxers over many years is linked to a higher risk of uterine cancer, especially among postmenopausal women.

Women who used these products heavily (at least 5 times per year over 15 years) showed a significant increase in uterine cancer rates compared to those who used them less frequently.

This association was particularly strong for those with prolonged use of 20 years or more, regardless of frequency.

Individuals who have used hair relaxers and developed cancer are encouraged to consult with a lawyer specializing in Hair Relaxer cancer lawsuits.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products, and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

As per Case Management Order No. 11, plaintiffs are required to submit their Short Form Complaints and Plaintiff Fact sheets for the Hair Relaxer Lawuit through an electronic database managed by a third party.

The platform centralizes document handling and ensures all parties have timely access to necessary files.

This system not only hosts but also tracks submissions and deadlines.

Plaintiffs must submit their documents and update case information in the database within strict deadlines.

Plaintiffs must ensure that their contact information is up-to-date in the filing system to receive automatic warning letters if documentation is overdue.

The court has outlined specific procedures for handling warning letters and deficiencies in submissions.

All data uploaded to the platform is handled securely, with specific protocols for accessing and updating information.

If you or a loved one has developed cancer or other health problems after using Hair Relaxer products, you may be eligible to file a claim. 

Contact TorHoerman law for a free consultation, or use the chatbot on this page to find out if you qualify for the Hair Straightener Lawsuit.

The Food and Drug Administration (FDA) missed its own April 2024 deadline to release a proposal to ban formaldehyde in hair-straightening products.

Formaldehyde and similar chemicals in these products are linked to cancer risks.

Research, including a National Institutes of Health study of over 33,000 Black women, indicates a correlation between regular use of hair relaxers and increased uterine cancer risk.

Affected women have filed lawsuits against major cosmetic companies like L’Preal and Revlon, though Revlon has previously stated there is no scientific support linking hair straighteners to cancer.

L’Oreal asserts its products do not contain formaldehyde yet supports the FDA’s proposed ban.

The Environmental Working Group has repeatedly petitioned the FDA to ban formaldehyde in hair products since 2011.

If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

A total of 8,468 cases are pending according to the most recent filings.

There have been 81 new cases sent to the Hair Relaxer MDL within the last month.

Hair Relaxer Lawsuits claim that manufacturers of these products failed to warn users about the risk of exposure to dangerous chemicals and their potential effects, such as an increased risk of developing uterine, ovarian, or breast cancer.

If you or a loved one developed cancer or other related health problems after prolonged use of hair relaxers, hair straighteners, and other similar products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact our law firm for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation and to get in touch with our Hair Relaxer Lawyers. 

The Food and Drug Administration (FDA) is reportedly planning to propose a ban on certain chemicals in hair relaxers, following evidence linking these products to cancer risks.

The regulatory action would target hair relaxers that include formaldehyde and other similar ingredients, due to their association with increased cancer risks, particularly respiratory tract cancers and myeloid leukemias.

These products often contain not only formaldehyde but also phthalates and other endocrine-disrupting chemicals that mimic hormones, potentially fostering cancer development.

The legal ramifications of these findings have already begun to take shape, as evidenced by the lawsuits filed against several hair straightener and relaxer manufacturers, including industry giant L’Oréal.

Our law firm is currently accepting new clients for the Hair Relaxer Lawsuit. 

Call us today for a free consultation, or use the chatbot on this page to find out if you qualify for the Hair Relaxer Lawsuit instantly.

As of the latest JPML filings, the number of Hair Relaxer lawsuits has reached 8,380 up from 8,334 on March 1st.

Hair relaxers, commonly used for straightening hair, have come under legal scrutiny due to allegations that certain chemicals present in these products may contribute to the development of various health conditions, including cancer.

Hair Relaxer Lawsuits claim that manufacturers failed to warn consumers about the risks associated with their use.

Cases are being filed by individuals who have used these products and subsequently experienced adverse health effects, seeking compensation for damages incurred.

For anyone who has used hair relaxers and is now facing health complications, it’s recommended to explore legal options.

If you or a loved one has suffered health complications linked to the use of hair relaxers, you may be eligible for the Hair Relaxer Lawsuit.

Call TorHoerman Law today for a free consultation, or you can also use the chatbot on this page to determine your eligibility.

117 cases were added to the Hair Relaxer Multidistrict Litigation (MDL) in the month of February, according to the most recent JPML filings.

In February, the JPML reported a total of 8,217 Hair Relaxer Lawsuits consolidated in the MDL.

The JPML numbers released on March 1st indicate an increase to 8,334 cases.

Hair Relaxer Cancer Lawsuits are being filed against various companies, including L’Oreal, Softsheen-Carson (Optimum Relaxer), Dark & Lovely, Just For Me, Motions Hair, ORS Hair Care (Namaste Laboratories, LLC), and African Pride (Godrej Group).

The Hair Relaxer Lawsuit claims that toxic substances in these products contribute to an increased risk for a variety of cancers.

If you or a loved one has experienced health issues believed to be caused by the use of hair relaxers, you may be eligible to participate in the Hair Relaxer Lawsuit. 

For detailed information and a free consultation, contact TorHoerman Law.

You can also use the chatbot on this page for immediate assistance and to determine if you qualify for the Hair Relaxer Lawsuit. 

As of February 2024, there are a total of 8,217 Hair Relaxer Lawsuits pending in the Hair Relaxer MDL according to the most recent JPML filings.

Multi-District Litigations (MDLs) are legal procedures in the United States designed to handle multiple related civil lawsuits that involve similar issues, facts, or defendants.

When numerous individuals or entities file lawsuits related to a common set of circumstances, such as product liability, pharmaceuticals, or mass tort cases, these cases can be consolidated into a single federal district court for pretrial proceedings.

MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

A recent study investigated the relationship between the use of chemical hair relaxers, commonly used by Black women in the US, and the risk of uterine cancer.

The research followed 44,798 Black women from 1997 to 2019 and found that heavy use of hair relaxers (15 years or more, at least 5 times a year) was associated with a slightly increased risk of uterine cancer.

Specifically, among postmenopausal women, moderate and heavy use of hair relaxers, as well as using them for over 20 years regardless of frequency, showed a higher risk of uterine cancer.

However, there was no significant association between hair relaxer use and uterine cancer risk among premenopausal women.

These findings suggest that long-term use of chemical hair relaxers may be a potential risk factor for uterine cancer, particularly in postmenopausal Black women.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

A federal judge, Illinois-based U.S. District Judge Mary Rowland, has allowed the majority of claims to proceed in a large-scale lawsuit alleging that chemical hair relaxer products manufactured by L’Oreal USA, Revlon, and other companies are responsible for causing cancer and other injuries.

Judge Rowland rejected most of the companies’ arguments in their attempt to dismiss the complaint in the multidistrict litigation involving over 8,000 lawsuits.

She determined that the plaintiffs had presented sufficient evidence to support their allegations, which include claims of negligence, defective product design, and a failure to warn customers about potential risks.

Out of the 15 claims in the complaint, Rowland dismissed three entirely and part of a fourth, citing insufficient support for the plaintiffs’ claims of fraud.

These hair relaxer products, primarily marketed to women of color, contain chemicals for permanently straightening textured hair.

The legal actions began following a National Institutes of Health study published in October 2022, which found that women using these products multiple times a year had more than twice the likelihood of developing uterine cancer.

Representatives from L’Oreal and Revlon did not immediately respond to requests for comment.

L’Oreal had previously expressed confidence in the safety of their products, while Revlon stated that they did not believe there was scientific evidence linking chemical hair straighteners or relaxers to cancer.

Smaller cosmetics companies, including some based in India, are also named in the lawsuits.

One of the lead attorneys for the consumers stated that the court’s ruling supports their argument that the products and the instructions provided by the companies are responsible for causing cancer.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

The Food and Drug Administration (FDA) is proposing a ban on the use of formaldehyde as an ingredient in hair relaxers, particularly in products used for hair-smoothing and hair-straightening, which are commonly used by Black women.

Formaldehyde is a toxic chemical that can irritate the eyes, skin, lungs, and throat and is linked to certain cancers, including myeloid leukemia.

The current FDA regulations don’t require approval of cosmetic products and ingredients before they reach the market, which has raised concerns about the safety of these products.

Recent research has highlighted the potential dangers of using chemical hair relaxers, with studies showing a higher risk of uterine cancer in women who used such products.

Hair relaxers often contain endocrine disruptors that can interfere with the body’s hormone system, leading to various health issues, including early onset of puberty, fibroid tumors, infertility, and lower fertility in women.

The FDA’s proposed ban comes after congressional representatives and advocates raised concerns about the safety of these products, particularly for Black women.

The target date for implementing the ban is April.

Additionally, policies like the CROWN Act, which prohibits discrimination based on hair texture, have gained momentum in multiple states to address issues related to hair and societal standards.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

• A deadline of August 30th, 2023, has been established for the submission of a joint written status report concerning a defendant’s McBride dismissal motions.
• Dermoviva Skin Essentials Inc. was previously removed from the class action earlier this month, but the possibility of its re-inclusion remains.

Discussions during the conference revolved around matters related to the discovery process, including talks about Federal Rule 26(a)(1) disclosures, particularly those involving expert witnesses.

There were also deliberations concerning 30(b)(6) depositions and electronic discovery (ESI).

A 30(b)(6) deposition allows an organization to designate representatives to testify on its behalf regarding specific topics or areas of inquiry.

The bankruptcy counsel provided an update to the court on the current status of Revlon’s bankruptcy proceedings and addressed subject matter jurisdiction matters pertaining to cases involving Revlon.

This week, Dabur International, the parent company of Namaste Laboratories and a key defendant in the hair relaxer class action lawsuit, made a significant legal change.

Dabur opted to substitute its previous defense counsel, who hailed from Kirkland & Ellis LLC, with a fresh team of attorneys from Baker & McKenzie LLP.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

The judge overseeing the hair relaxer lawsuit approved the use of a short-form complaint, which allows new plaintiffs to fill out a more general form to join the multidistrict litigation (MDL) centralized in the US District Court for the Northern District of Illinois.

The short-form requires the plaintiff to answer two questions:

1. What type(s) of hair relaxer was used
2. What injury/ injuries resulted from the use of hair relaxers.

The document specifically mentions uterine cancer, endometrial cancer, and ovarian cancer, but other health problems experienced by women who’ve used hair relaxers, such as endometriosis or endometrial cancer, may qualify.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

In a hair relaxer multidistrict litigation (MDL), manufacturers of various hair products, including ORS Olive Oil, Dark & Lovely, Just for Me, and Optimum, have filed a motion to dismiss the product liability lawsuits.

The plaintiffs allege that their products are linked to higher rates of uterine cancer, ovarian cancer, endometrial cancer, endometriosis, and other injuries.

L’Oréal, Revlon, Strength of Nature, and Namaste have also joined the motion to dismiss the lawsuits.

The manufacturers argue that the plaintiffs’ complaint fails to identify specific ingredient formulations and products responsible for the alleged injuries.

The MDL, overseen by U.S. District Judge Mary M. Rowland in the Northern District of Illinois, was approved in February.

The Master Complaint outlines common allegations made by women, mostly African American, who claim to have developed uterine or ovarian cancer due to regular exposure to hormone-altering synthetic chemical compounds in the hair relaxer products.

The plaintiffs argue that they were not adequately warned about the cancer risks associated with using these products.

Currently in the pre-trial phase, the MDL is coordinating a discovery schedule.

The defendants’ attorneys seek a two-phase discovery process, with the first phase focused on establishing direct causation between hair relaxers and cancer.

If causation is proven, further factors in the discovery process will proceed.

The plaintiffs’ attorneys contend that this two-phase discovery process is merely a delay tactic.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

Revlon has submitted an update to the MDL judge regarding their ongoing bankruptcy proceedings and a response to the plaintiffs’ status report filed on June 30th, 2023.

Despite being in bankruptcy, Revlon is significant due to its substantial insurance policy that covers lawsuits related to hair relaxer and cancer.

According to Revlon, the plaintiffs’ report inaccurately represents certain aspects of the bankruptcy proceedings and highlights concerns that have already been addressed.

The update provided by Revlon includes detailed provisions of the bankruptcy proceedings and the confirmation order, which aim to guide the court in understanding the potential implications on the MDL class action lawsuit.

Revlon emphasizes that any claims against them must adhere to the bankruptcy court’s order and the specified proof-of-claim procedures.

Plaintiffs can only assert “Hair Straightening Claims” in the MDL proceedings or in the Southern District of New York after filing a valid proof of claim.

As per the provisions outlined in the Plan, potential plaintiffs need to file a complaint related to hair straightening against Revlon before September 14th, 2023.

If these claims are not covered by Revlon’s insurance, any recovery through settlement or judgment is considered discharged in bankruptcy.

Recently, Revlon submitted an omnibus objection to multiple proofs of claim, including those from approximately 3,000 hair straightening claimants, and they anticipate filing more objections.

In their update to the court, Revlon criticized the plaintiffs’ lawyers’ status report, claiming it inaccurately portrayed the bankruptcy court’s order.

They also pointed out that the hair-straightening-claim objections had already been resolved prior to the bankruptcy court’s hearing on the objections, which was omitted in the report.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

Research into the health impacts of hair relaxer use is ongoing, with a new study published by the Boston University School of Public Health linking hair relaxers to an increased risk of infertility.

The study discovered that hair relaxers contain endocrine-disrupting compounds, which hinder fertility.

The study says that current and former hair relaxer users have an increased risk of infertility, and the greater the frequency and/ or duration of use further increases these risks.

Participants in the study who used relaxers for at least 10 years or at least five times per year had the lowest fertility rates.

The researchers listed phthalates, phenols, and parabens as some of the chemicals found in hair relaxers that reduce fertility, and they further stated that a full set of ingredients and chemicals is rarely included on hair relaxer product labels.

This means that even if hair relaxers do not list certain chemicals on their labels, they can still contain chemicals that hinder fertility and are linked to other serious health conditions like uterine cancer.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly.

On May 22, the plaintiffs in the litigation filed a master complaint.

A master complaint takes the similar allegations from every case in the multidistrict litigation (MDL) and combines them onto a single document, allowing for current and new cases with corresponding allegations to be organized as one.

By combining hundreds of individual cases through a master complaint, the MDL pre-trial process becomes simpler and more efficient.

Each individual case will have to submit an individual short-form complaint, which refers a plaintiff’s single case to the overarching master complaint in the litigation.

This filing of the master complaint indicates pre-trial processes will begin to move more quickly.

Visit this page for more updates on the Hair Relaxer Lawsuit, and contact our law firm if you have any questions or concerns about your potential Hair Relaxer Lawsuit.

If you or a loved one frequently used hair relaxers, chemical hair straighteners, or other hair straightening products and were subsequently diagnosed with uterine cancer or another cancer related to these products, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly. 

Our Hair Relaxer Lawyers are speaking to potential clients and assessing eligibility to join the Hair Relaxer Litigation.

More and more cases are being added to the Hair Relaxer MDL, which is centralized in the US District Court for the Northern District of Illinois.

The litigation is targeting manufacturers and distributors of hair products that contain volatile organic compounds (VOCs) that have been linked to cancer, specifically uterine cancer risk.

Researchers at Johns Hopkins University conducted a study on Black and Hispanic hairdressers, finding that many have been exposed to hazardous chemicals in hair products that may increase the risk for developing cancer.

The impacts of toxic chemicals in hair relaxers and other hair products is not limited to those who have the products applied to their hair.

Hair stylists and hairdressers who frequently use these products may also be at an increased risk for cancer.

The Hair Relaxer Lawsuit is ongoing and lawyers across the country are accepting new clients.

More and more Hair Relaxer Lawsuits are being consolidated into multidistrict litigation (MDL 3060) in the US District Court for the Northern District of Illinois.

As mentioned in last month’s update, the ability for new claimants to file directly into the MDL will help us to better understand how many claims are out there and the pace at which they are filed.

We are expecting the Hair Relaxer Lawsuit to be significant as millions of women have used these products for decades, and until recently, may have been unaware that the usage of chemical hair straightening products could have contributed to uterine cancer diagnoses.

If you or a loved one used Hair Relaxers, Chemical Hair Straighteners, or other Hair Straightening Products and subsequently developed Uterine Cancer or other linked medical conditions, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for the Hair Straightener Cancer Lawsuit instantly. We’re here to help. 

Judge Rowland, who is presiding over the Hair Relaxer MDL, will now allow cases to be directly filed in the MDL.

This move will make it easier for lawyers and their clients.

Rather than having plaintiffs file in courts across the country and later consolidate in the MDL, claims can be filed directly into the MDL using a short form complaint.

If you or a loved one have been diagnosed with uterine cancer or another related medical condition after frequent use of hair relaxers, contact TorHoerman Law for a free consultation.

You can also use the chatbot on this site to get a free case evaluation and find out if you qualify in under two minutes.

More and more hair relaxer lawsuits are being centralized in the multidistrict litigation (MDL) in the US District Court: Northern District of Illinois.

Defendants named in the lawsuits include multiple companies owned by L’Oreal USA, Dabur International Ltd., Namasté Laboratories LLC, Strength of Nature LLC, Godrej SON Holdings Inc., House of Cheatham, and more.

If you or a loved one used chemical hair straighteners, hair relaxers, or other similar products and subsequently suffered, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation or use the chatbot on this page to see if you qualify for legal action instantly.

The Judicial Panel on Multidistrict Litigation (JPML) has centralized lawsuits against L’Oréal and other beauty companies into an MDL in the US District Court: Northern District of Illinois.

Around 60 lawsuits claiming that hair relaxer products sold by L’Oréal and other beauty companies cause cancer and other health problems will be consolidated.

The lawsuits allege that the companies knew their products contained dangerous chemicals, but still marketed and sold them.

If you or a loved one used hair straightening chemicals, hair relaxers, or any other similar hair products and were subsequently diagnosed with cancer or other health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

Hair Relaxer and Hair Straightener Lawsuits are being filed in state courts across the United States.

The litigation against manufacturers of these products is growing, and lawyers from around the country are accepting clients.

The Hair Straightener Lawsuit has also crossed the border with a new class action lawsuit filed in Canadian court against L’Oreal.

The proposed class action filed in the British Columbia Supreme Court claims the products contain hormonally active and carcinogenic compounds that are not listed separately as ingredients, but are instead often grouped into the “fragrance” or “perfume” categories.

The claim accuses the companies of extensive misconduct, including failing to investigate reports of adverse effects, issue recalls or warn customers and health professionals.

Do you qualify for a Hair Straightener Lawsuit?

Contact us for a free consultation or use the chatbot on this page to see if you qualify to file a claim instantly.